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ABSTRACT 
Objective: Hydrogels with scope for utilization in numerous fields possess limited applications due to problems in incorporating wide range of drugs 
and crossing the lipophilic barrier of the skin. Attempts to overcome these problems by developing organogel hold drawbacks. Challenges posed by drug 
lipophilicity or skin permeation can be solved by developing bigel formed via combination of lipophilic and hydrophilic gel phases in a definite 
proportion. The objective of the present study is to formulate and characterize matrix type bigel of soybean oil and HPMCK4M for topical drug delivery. 
Methods: Four batches of bigels were developed with two organogel formulations of soybean oil containing 20 and 22% w/v Span 60. Both 
organogels and bigels were examined for compatibility by FTIR spectroscopy, hemocompatibility and characterized for physical appearance, pH, 
rheological behavior and in vitro drug release pattern.  
Results: FTIR study confirmed compatibility between paracetamol and components of organogel or bigel. The oily feel of organogels disappeared with 
bigels which possessed a creamy and smooth texture. Pseudoplastic behaviour was confirmed by Ostwald-de wale power-law model in both organogels 
and bigels. Improved drug release was observed in bigel (BG1) formulation containing 3%w/v HPMCK4M and soybean oil based organogel with 20% 
w/v Span 60 as compared to the corresponding organogel (OG1). Organogels were foundto follow either zero-order kinetics (OG1) or Korsmeyer-
Peppasmodel (OG2) while the formation of matrix was exhibited in bigels with drug diffusion predominantly of non-Fickian type. 
Conclusion: Therefore, bigels of soybean oil based organogel with HPMCK4M hydrogel formed gel matrix demonstrating improved drug release for 
topical application compared to organogel. 
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Gels are semi-solid bases in which a liquid phase is entrapped within a 
three dimensionalpolymeric network forming a supra-molecular 
architecture which has a wide range of applications in medicine, 
biomaterials, cosmetics and food industries. In general, depending on 
the polarity of the liquid phase, gels have been categorized as either 
hydrogels (polar solvent: water) or organogels (non-polar solvents: 
organic liquids, vegetable oils etc.) [1]. Hydrogels have extensive 
applications in tissue engineering, food and pharmaceutical industry 
[2]. They appeal to patients/consumers owing to their non-oily feel, 
cooling effect and water-washability. But they have limited ability to 
accommodate wide range of drugs and to cross the lipophilic stratum 
corneum [3]. Attempts were made to overcome these drawbacks by 
developing organogels and emulgels.  
Organogels were being investigated since early1990s [4, 5]. 
Emulgels are oil-in-water or water-in-oil emulsions, gelled by mixing 
with a crosslinker [6, 7]. But due to their stickiness and oily residues, 
emulgels and organogels have been less appreciated by consumers. 
Moreover, the leaching of the internal oil phase from these gels on 
long-term storage has forced scientists to look for stable 
formulations [8]. This problemmay be attributed to the mismatch in 
the mechanical properties of the internal and the external phases. To 
overcome this problem, the concept of bigels was introduced in 
2008 by Almeida et al. [9]. Bigels are biphasic systems like 
emulsions and emulgels, where both internal and external phases 
are semisolid in nature [10]. Microscopic study of bigels using 
sesame oil/soybean oil based organogel and gelatin based emulgel 
revealed the aggregation of droplets whereas emulgel showed 
dispersed droplets within the continuous phase. They are reported 
to show negligible amount of leaching of internal phases as 
compared to the emulgel and in vitro drug release studies indicated 
non-Fickian diffusion from the bigel matrices [11]. 
Bigels can be defined as a mixture of an aqueous gel (hydrogel) and 
an organogel in a definite ratio [9, 12]. They differ from emulsions, 
creams and emulgels as they do not require surfactant-based 
stabilizer [13]. Oil-based do not show demixing of the two phases on 
storage at room-temperature for a period of up to 6-12 mo [14]. 
They are stabilized by entrapment of the mobile phases via a three-
dimensional gel network resulting in an extra-fine dispersion. 
Electrical conductivity of bigels has been ascribed to the presence of 
pockets of water [9]. As a pharmaceutical formulation, bigels 
possess many advantages over other semi-solid systems owing to 
the synergistic effect of both gels, ease of preparation, satisfactory 
stability, viscosity, spreadability, microarchitecture, absence of 
surfactant related skin toxicity and possible delivery of both 
lipophilic and hydrophilic drugs [15]. 
The aim of the present study was to develop and characterize 
organogel-in-hydrogel type bigels of soybean oil-based organogel 
with HPMCK4M hydrogel. Four different types of bigel formulations 
have been prepared by choosing two organogels containing 20 and 
22%w/v Span 60 as organogelator. They were characterized for in 
vitro drug release profile for topical application. 
MATERIALS AND METHODS 
Materials 
Food grade soybean oil (Emami Ltd., Kolkata) was purchased from 
local market. Paracetamol IP (PCM) was received as a gift sample 
from enlisted vendor. Span 60 (sorbitan monostearate) was 
purchased from Loba Chemie Pvt. Ltd., Mumbai. HPMCK4M was of 
AR grade and obtained from Colorcon Asia Pvt. Ltd. as gift sample. 
All other reagents were of analytical grade. 
Methods 
Method of preparation of gel 
The organogel was prepared by adding required quantity of Span 60 
in soybean oil maintained at 60 ℃ with continuous stirring (500 
rpm). The hot dispersion turned into organogel when left 
undisturbed and cooled down to 25 ℃. The drug-loaded organogel 
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was prepared by addition of paracetamol (PCM) followed by 
addition of Span 60. 
The hydrogel was prepared by stirring a definite quantity of 
HPMCK4M in warm distilled water (65 ℃) at 500 rpm to obtain a 
viscous dispersion (3-5% w/v). The organogel in sol state was 
added to HPMC aqueous dispersion maintained at 60-70℃ under 
stirring at 500 rpm [16]. The stirring was continued until a 
homogenous mixture was obtained. The mixture formed bigel when 
cooled to 25 ℃. Propylparaben (0.02% w/v) was added to prevent 
bacterial contamination of the hydrogel. Compositions of the various 
formulations are provided in table 1. 
 
Table 1: Composition of Span 60 based organogels and bigels of soybean oil 
Formulation Organogel (OG) Hydrogel(HG) 
%w/v %w/v 
Paracetamol Span 60 Oil HPMCK4M Water 
OG1 2 20 78 - - 
OG2 2 22 76 - - 
HG1 - - - 3 97 
HG2 - - - 4 96 
(OG: HG =1:1)      
BG1 2 20 78 3 97 
BG2 2 20 78 4 96 
BG3 2 22 76 3 97 
BG4 2 22 76 4 96 
 
Characterization of the formulations 
FTIR spectroscopy 
FTIR analysis of blank organogel and hydrogel, as well as drug loaded 
formulations along with its individual components, was carried out 
using Fourier Transformed Infrared Spectrometer (ALPHA-II, Bruker, 
Bellerica, MA, USA) operated in Attenuated Total Reflectance (ATR) 
mode. Samples were scanned in the range of 4000 to 500 cm-1 [16]. 
Physical evaluation 
Formulations were observed visually for their colour, appearance, 
texture and opacity [17]. 
Determination of pH 
The pH of the formulations was determined using digital pH meter 
(Fisher Scientific-Accumet AE 150) [17]. 
Extrudability 
A definite weight of gel was filled into an ointment tube and 
crimped. The extrudability (cm/s) of gel was determined by 
measuring the length of the gel ribbon extruded from the ointment 
tube by applying uniform pressure over a period of 10 s [18]. The 
following equation was used to determine extrudability. 
Extrudability = Distance travelled by the gel (cm)/10 s (1) 
Spreadability 
Spreadability of the formulations was determined by placing 0.1 g 
gel between two glass slides of equal dimensions (75 mm×25 mm×1 
mm). Thereafter, known weights of 10 g, 20 g, 50 g or 100 g were 
loaded on the upper slide for 60 s. The initial and final spreading 
diameters were marked before and after placing the individual 
weight [19]. Finally, the % spreadability may be calculated by using 
the following equation.  
% Spreadability = [(Di-Df)/Di] ×100 ……….. (2) 
Where, Di = initial spreading diameter, Df= final spreading diameter 
Rheological study 
The viscosity of the blank gels (organogel and bigel)were measured 
in Brookfield Digital Viscometer (Model LVDVI+, Brookfield 
Engineering Laboratories Inc, USA) with spindle no. 7 at 25 ⁰C  [20]. 
The apparent viscosity of organogel and bigel formulations of 
different compositions was measured as a function of shear rate 
varying from 1 to 5 rpm. Ostwald-de wale power-law model has 
been employed to analyze the flow behavior of organogel as well as 
bigel systems given as follows:  
Ʈ=k*ɤn ………….. (3) 
Where the relationship between stress (Ʈ) and shear rate ( ɤ) give 
the values for flow consistency index (k) and flow behaviour index 
(n). The rheological behavior may be stated as non-Newtonian 
pseudoplastic/shear-thinning if the values of n is<1 [21, 22]. 
Thermal analysis 
The gel-sol transition temperature (Tg) of the organogels was 
determined by falling ball method [23]. Briefly, a metal ball of weight 
250 mg was placed gently on the surface of the organogel taken in a 
beaker. A thermometer was inserted in the gel and the gel was heated 
from 25 to 70 ℃ at a rate of 1 ℃/min. The temperature at which the 
ball started to move from the surface through the gel was recorded as 
the gel-sol transition temperature (Tg). This method could not be used 
for bigels due to phase separation occurring simultaneously with 
phase transition at temperature higher than 50 ℃. Bigels are reported 
to lose their stability and structure at higher temperatures [24]. 
Drug content determination 
Definite amount of drug-loaded gels was added to phosphate buffer (pH 
5.8) which was kept undisturbed for 48 h for complete leaching of drug 
[25]. The dispersion was filtered through Whatman filter paper No. 1. An 
aliquot of filtrate was suitably diluted and absorbance measured 
spectrophotometrically at 249 nm (Shimadzu UV-VIS 1800 
spectrophotometer) [26]. The drug content of formulations was 
determined from the calibration curve of the drug in the said buffer. 
In vitro drug release study 
In vitro drug release from organogels and bigels was performed 
through dialysis membrane (HIMEDIA® LA 330-5MT) in modified 
Franz diffusion cell [27]. Accurately weighed drug-loaded sample 
containing drug equivalent to4 mg was placed in the donor 
compartment and the receptor chamber containing phosphate 
buffer (pH 5.8) was maintained at 32±0.5 ℃. An aliquot of 1  ml was 
withdrawn every hour, replenished with fresh buffer and study was 
continued for 7 h. The aliquot was analyzed spectrophotometrically 
at 249 nm (Shimadzu UV-VIS 1800 spectrophotometer) [26]. 
Drug release data were subjected to mathematical modeling by using 
zero-order, first order, Higuchi and Korsmeyer-Peppas models [28]. 
Hemocompatibility study  
Accurately weighed amount of blank organogel and bigel was placed in 
dialysis tube filled with 50 ml normal saline (0.9% w/v NaCl solution) 
and continuously stirred in a magnetic stirrer for 1 h at 37 ℃ in order to 
enable leaching of the gel components. Leachant (0.5 ml) was 
withdrawn, diluted to 10 ml with normal saline and 0.5 ml diluted goat 
blood (4 ml of goat blood diluted with 5 ml of normal saline) and 
incubated at 37 ᵒC for 1 h. It was then centrifuged at 3000 rpm for 10 
min. The supernatant was measured spectrophotometrically at 542 nm. 
Positive control was prepared by taking 0.1 (N) HCl solution in lieu of 
Mukherjee et al. 
Int J App Pharm, Vol 11, Issue 5, 2019, 33-38 
35 
leachant. In negative control, normal saline was used instead of leachant. 
Normal saline was taken as the corresponding blank and percent 
haemolysis may be calculated as follows [29]:  
% Haemolysis = (OD test-OD negative) / (OD positive-OD negative) × 100 … (4) 
Where, OD test = Absorbance of the test sample 
OD positive = Absorbance of the positive control 
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Statistical analysis 
All the experiments were performed in triplicate. All data were 
expressed as mean±standard deviation (SD). ANOVA was used to 
calculate significant differences between the experimental data. The 
p-value less or equal to 0.05 was considered to be statistically 
significant [30]. 
RESULTS 
Formation of gel 
Non-flowing bigel was formed within 10 min whereas organogel 
formation occurred in less than 5 min.  
FTIR study 
The FTIR spectra of blank organogel (OG*) and drug-loaded 
formulations (OG2 andBG4) are shown in fig. 1. Major peaks of 
individual components could be detected in the corresponding 
organogel and bigel. No new peaks could be seen. 
Physical evaluation and pH determination 
Organogels appeared to be creamy white in colour with good 
consistency. Bigels were found to be milky white with smooth, non-
greasy and creamy texture. pH of the formulations was found to be in the 
range 5.35 to 6.1 at 25 ℃ which was close to skin pH (4.5-6.5) (table 2). 
Extrudability and spreadability 
Extrudability and spreadability data of both organogels and bigels 
are presented in table 3. 
Rheological study 
Viscosities of the gel formulations are graphically represented (fig. 
2). The flow index ‘n’ was found to be less than 1 in all cases. 
 
Table 2: Organoleptic properties and pH values of Span 60 based organogels and bigels of soybean oil. *Data presented as mean±standard 
error of mean from n=3. p<0.05 indicating statistically significant differences 
Formulation Colour Odor Appearance Opacity pH at 25 ℃* 
OG1 Creamy white Odorless Greasy Opaque 5.51±0.16 
OG2 Creamy white Odorless Greasy Opaque 5.26±0.35 
BG1 Milky white Odorless Smooth non-oily Opaque 5.81±0.47 
BG2 Milky white Odorless Smooth non-oily Opaque 5.35±0.14 
BG3 Milky white Odorless Smooth non-oily Opaque 5.98±0.38 
BG4 Milky white Odorless Smooth non-oily Opaque 6.10±0.32 
 
Table 3: Extrudability, spreadability and hemocompatibility data of span 60 based organogels and bigels of soybean oil. *Data presented 
as mean±standard error of mean from n=3. p<0.05 indicating statistically significant differences 
Formulation Extrudability* (cm/s) % Spreadability on applying % Hemocompatibility 
10g 20g 50g 100g 
OG1 0.78±0.35 37.49 45.26 74.85 92.76 3.84 
OG2 0.76±0.16 33.33 46.15 57.89 97.43 3.52 
BG1 0.75±0.24 28.34 39.17 50.84 95.45 2.45 
BG2 0.72±0.13 24.18 32.61 45.85 92.49 3.17 
BG3 0.78±0.38 29.59 35.48 56.17 94.25 1.35 
BG4 0.76±0.34 22.14 34.31 52.17 92.52 2.49 
 
 
Fig. 2: Shear rate vs viscosity graph of Span 60 based organogels and bigels of soybean oil 
 
Thermal analysis 
Gel-sol transition temperatures of OG1 and OG2 were found to be 59 
and 63℃ respectively.  
Drug content determination 
Drug content of organogels (OG1 and OG2) was found to be in 
between 90-93% whereas it was found to be in the range 85-92%. 
In vitro drug release with kinetic modelling 
Only ~27% drug release was observed from organogels, OG1 and OG 
2 containing 20 and 22% w/v Span 60 respectively while it varied 
between 40 to 54% in HPMCK4M based bigels (fig. 3). However, it 
was noted that an increase in the concentration of HPMC in hydrogel 
lowered release of PCM from the bigels which was still better than 
that from organogels. 
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Table 4: Modelling of drug release kinetics from Span 60 based organogels and bigels of soybean oil 
Formulation Zero order model Higuchi model Korsmeyer-Peppas model Type of diffusion 
R2 R2 R2 n 
OG1 0.997 - - 0.57 non-Fickian diffusion 
OG2 - - 0.992 0.70 non-Fickian diffusion 
BG1 - 0.989 - 0.23 NP* 
BG2 - 0.978 - 0.50 non-Fickian diffusion 
BG3 - 0.947 - 0.37 NP* 
BG4 - 0.987 - 0.57 non-Fickian diffusion 
NP*: not possible to comment 
 
Kinetic modeling of drug release from organogel indicated zero-
order kinetics and Korsmeyer-Peppas model respectively with non-
Fickian diffusion (0.45<n<0.89). However, it has been found to 
follow Higuchi model in the bigels (table 4). In case of bigels with 
lower %w/v of HPMC, no decision could be taken regarding the type 
of diffusion as ‘n’ value was found to be out of conventional range. 
  
 
Fig. 3: Drug release from Span 60 based organogels and bigels of soybean oil. Data presented as mean±standard error of mean from n=3. 
p<0.05 indicating statistically significant differences 
 
Hemocompatibility study 
The % hemolysis of all the formulations was found to be less than 
5% in presence of organogel and bigel leachant and thus 
hemocompatible (table 3). 
DISCUSSION 
Visual appearance and feel of topical preparation is an important 
characteristic as it affects the choice and compliance of the patient. 
The smooth and creamy texture of bigels may be attributed to the 
uniform mixing of otherwise two immiscible phases owing to the 
presence of Span 60, a surface-active agent [31].  
FTIR spectra indicate that the principal peaks present in the raw 
materials (Soybean oil, Span 60, HPMCK4M and paracetamol) were 
preserved in the drug-loaded bigels [16]. 
The viscosities of both organogels and bigels showed concentration-
dependent behavior, i.e. increase in viscosity with increase in 
oraganogelator or aqueous gelling agent (HPMC) concentration. The 
bigels (BG1 and BG2) formulated with organogel containing 20% 
w/v Span (OG1) were found to possess higher viscosity than OG1. 
However, an anomalous behavior was observed with bigels (BG3 
and BG4) of organogel developed with 22%w/v Span (OG 2) where 
viscosity is lower than the corresponding organogel. In case of BG3 
and BG4 with higher % of organogelator which is primarily a 
surfactant, probably an emulgel of lower viscosity would have been 
formed on addition of 3 and 4% w/v HPMC gels. Lower % of Span in 
OG1 did not promote emulgel formulation in the bigels (BG1 and BG 
2) and hence, their viscosities are higher than the corresponding 
organogel. Both organogel and bigel formulations demonstrated 
non-Newtonian pseudoplastic flow and shear thinning behavior 
similar to that observed with sunflower oil and protein based novel 
bigels as matrices for drug delivery applications as reported by 
Behera et al. [21]. 
As the temperature of the organogels was increased there was a 
corresponding increase in surface free energy with subsequent 
increase in mobility of the gelator molecules constituting the 3D-self 
assembled structure of the formulations, leading to sol formation. 
Thermal stability of the organogels was enhanced by increasing the 
concentration of organogelator. [33]. 
Bigel formation was found to enhance drug release. Drug release via 
non-Fickian diffusion phenomenon followed either zero-order 
kinetics from organogel with lower % (20%w/v) Span or 
Korsmeyer-Peppas model from organogel with 22%w/v Span. 
However, bigels are assumed to form matrix as drug release 
followed Higuchi kinetics. Similar behavior was reported by Rehman 
et al. (2014) in their studies on polymer-fish oil bigel system as 
transdermal drug delivery vehicle [32]. It is to be noted that non-
Fickian diffusion occurred from the organogels and bigels with 
4%w/v HPMCK4M irrespective of concentration of organogelator. 
Improved drug release from bigels can be explained by the swelling-
induced gradual break-up of the gel matrix into smaller fragments as 
the gel skeleton is compromised by the influx of dissolution medium 
via the channels offered by the tubular structure of gelator 
molecules. In case of BG 2 and BG 4, swollen but highly dense and 
compacted structure imparted by higher concentration of HPMC 
hydrogel presumably failed to cause maximum stressing and 
expansion of organogel core and thus retarded drug release. 
Moreover, higher concentration of HPMCK 4M in BG 3 and BG 4 
hindered drug release from the gel-matrix due to formation of high-
viscosity drug diffusion barrier. 
CONCLUSION 
From the above studies it can thus be concluded that pseudoplastic 
bigels with HPMC formed matrix where drug release improved 
significantly in comparison to Span 60 based organogels of soybean 
oil.  
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